Quidel Corporation operates in the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Quidel with three other
companies in this sector in the United States:
Peregrine Pharmaceuticals, Inc.
sales of $44.69 million
of which 99%
was Contract Manufacturing and Development o),
of which 55%
was Animal Safety), and
Meridian Bioscience, Inc.
of which 74%
was US Diagnostics).
Quidel reported sales of $191.60 million
December of 2016.
decrease of 2.3%
versus 2015, when the company's sales were $196.13 million.